Patents by Inventor James Lalonde

James Lalonde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11894987
    Abstract: Systems and methods include receiving Operations, Administration, Maintenance, and Provisioning (OAM&P) data from an optical network; providing a Graphical User Interface (GUI) based on the OAM&P data with the GUI including a topology view; and providing a visualization that includes one of a power readings graph, a spectral analysis graph, and a spectral allocation graph, in the GUI, and the visualization is positioned logically next to the topology view.
    Type: Grant
    Filed: September 19, 2022
    Date of Patent: February 6, 2024
    Assignee: Ciena Corporation
    Inventors: Tommaso D'Ippolito, Christiane Louise Campbell, Sonya Thornley, Yuen Ping Choi, Philippe Vic Savignac, Frederick James Lalonde, Michael Wilgosh
  • Publication number: 20230083867
    Abstract: Systems and methods include receiving Operations, Administration, Maintenance, and Provisioning (OAM&P) data from an optical network; providing a Graphical User Interface (GUI) based on the OAM&P data with the GUI including a topology view; and providing a visualization that includes one of a power readings graph, a spectral analysis graph, and a spectral allocation graph, in the GUI, and the visualization is positioned logically next to the topology view.
    Type: Application
    Filed: September 19, 2022
    Publication date: March 16, 2023
    Inventors: Tommaso D'Ippolito, Christiane Louise Campbell, Sonya Thornley, Yuen Ping Choi, Philippe Vic Savignac, Frederick James Lalonde, Michael Wilgosh
  • Patent number: 11463325
    Abstract: A network management system includes a network interface communicatively coupled to one or more network elements in a network for exchanging Operations, Administration, Maintenance, and Provisioning (OAM&P) data; a processor communicatively coupled to the network interface; and memory storing instructions that, when executed, cause the processor to obtain the OAM&P data from the network, provide a Graphical User Interface (GUI) based on the network from the OAM&P data, wherein the GUI includes a network map which provides a topological view and a subway view which provides a detailed device-level view which is more granular than the network map and illustrates individual components at each site, receive a selection from a user of a service in the network, and update the GUI to highlight the service in the network map and illustrate the associated sites in the subway view.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: October 4, 2022
    Assignee: Ciena Corporation
    Inventors: Tommaso D'Ippolito, Christiane Louise Campbell, Sonya Thornley, Yuen Ping Choi, Philippe Vic Savignac, Frederick James Lalonde, Michael Wilgosh
  • Publication number: 20190215248
    Abstract: A network management system includes a network interface communicatively coupled to one or more network elements in a network for exchanging Operations, Administration, Maintenance, and Provisioning (OAM&P) data; a processor communicatively coupled to the network interface; and memory storing instructions that, when executed, cause the processor to obtain the OAM&P data from the network, provide a Graphical User Interface (GUI) based on the network from the OAM&P data, wherein the GUI includes a network map which provides a topological view and a subway view which provides a detailed device-level view which is more granular than the network map and illustrates individual components at each site, receive a selection from a user of a service in the network, and update the GUI to highlight the service in the network map and illustrate the associated sites in the subway view.
    Type: Application
    Filed: June 28, 2018
    Publication date: July 11, 2019
    Inventors: Tommaso D'Ippolito, Christiane Louise Campbell, Sonya Thornley, Yuen Ping Choi, Philippe Vic Savignac, Frederick James Lalonde, Michael Wilgosh
  • Patent number: 9357278
    Abstract: A method of managing an optical communication network having a plurality of nodes, the plurality of nodes including at least one regeneration site. A respective Path Computation Element (PCE) function is instantiated and associated with each regeneration site in the network. Each PCE function maintains a reach table containing information of viable optical paths extending from transceivers of its regeneration site. The PCE function implements a Recursive Path Computation algorithm to compute end-to-end routes through a physical layer of the network.
    Type: Grant
    Filed: December 17, 2012
    Date of Patent: May 31, 2016
    Assignee: Ciena Corporation
    Inventors: Gerard Leo Swinkels, Frederick James LaLonde, Michael Stanley Wilgosh
  • Patent number: 8962285
    Abstract: The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize chiral compounds.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: February 24, 2015
    Assignee: Codexis, Inc.
    Inventors: Jack Liang, Stephane J. Jenne, Emily Mundorff, Rama Voladri, James LaLonde, Gjalt W. Huisman
  • Patent number: 8859784
    Abstract: The present disclosure provides substantially enantiomerically pure heterobicyclic compounds of the following structural formulas, wherein A, M, M?, and R5 are as described herein, and to biocatalytic processes for their preparation, and to the enzymes used in those processes.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: October 14, 2014
    Assignee: Codexis, Inc.
    Inventors: Jack Liang, James Lalonde, Jun Zhu, John M. Gruber, John D. Munger, Jr.
  • Patent number: 8852900
    Abstract: The present disclosure provides engineered transaminase polypeptides having improved properties as compared to naturally occurring transaminases including the ability of converting the substrate, 3?-hydroxyacetophenone to (S)-3-(1-aminoethyl)-phenol in enantiomeric excess and high percentage conversion. Also provided are polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to synthesize (S)-3-(1-aminoethyl)-phenol and related compounds useful in the production of active pharmaceutical ingredients.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: October 7, 2014
    Assignee: Codexis, Inc.
    Inventors: Fabien Cabirol, Anupam Gohel, Seong Ho Oh, Derek Smith, Brian Wong, James Lalonde
  • Publication number: 20140169791
    Abstract: A method of managing an optical communication network having a plurality of nodes, the plurality of nodes including at least one regeneration site. A respective Path Computation Element (PCE) function is instantiated and associated with each regeneration site in the network. Each PCE function maintains a reach table containing information of viable optical paths extending from transceivers of its regeneration site. The PCE function implements a Recursive Path Computation algorithm to compute end-to-end routes through a physical layer of the network.
    Type: Application
    Filed: December 17, 2012
    Publication date: June 19, 2014
    Inventors: Gerard LEO SWINKELS, Frederick James LALONDE, Michael Stanley WILGOSH
  • Patent number: 8617864
    Abstract: The present disclosure provides ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, method of using the engineered ketoreductase enzymes to synthesize a variety of chirally pure compounds, and the chirally pure compounds prepared therewith.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: December 31, 2013
    Assignee: Codexis, Inc.
    Inventors: Lorraine Joan Giver, Lisa Marie Newman, Emily Mundorff, Gjalt W. Huisman, Stephane J. Jenne, Jun Zhu, Behnaz Behrouzian, John H. Grate, James Lalonde
  • Patent number: 8617853
    Abstract: The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds.
    Type: Grant
    Filed: December 19, 2011
    Date of Patent: December 31, 2013
    Assignee: Codexis, Inc.
    Inventors: Jack Liang, Birthe Borup, Vesna Mitchell, Emily Mundorff, James Lalonde, Gjalt Huisman
  • Patent number: 8574876
    Abstract: The present disclosure provides substantially enantiomerically pure heterobicyclic compounds of the following structural formulas, wherein A, M, M?, and R5 are as described herein, and to biocatalytic processes for their preparation, and to the enzymes used in those processes.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: November 5, 2013
    Assignee: Codexis, Inc.
    Inventors: Benjamin Mijts, Sheela Muley, Jack Liang, Lisa M. Newman, Xiyun Zhang, James Lalonde, Michael D. Clay, Jun Zhu, John M. Gruber, Jeffrey Colbeck, John D. Munger, Jr., Jagadeesh Mavinahalli, Roger Sheldon
  • Publication number: 20130089898
    Abstract: The present disclosure provides engineered transaminase polypeptides having improved properties as compared to naturally occurring transaminases including the ability of converting the substrate, 3?-hydroxyacetophenone to (S)-3-(1-aminoethyl)-phenol in enantiomeric excess and high percentage conversion. Also provided are polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to synthesize (S)-3-(1-aminoethyl)-phenol and related compounds useful in the production of active pharmaceutical ingredients.
    Type: Application
    Filed: June 16, 2011
    Publication date: April 11, 2013
    Applicant: CODEXIS, INC.
    Inventors: Fabien Cabirol, Anupam Gohel, Seong Ho Oh, Derek Smith, Brian Wong, James Lalonde
  • Publication number: 20130040364
    Abstract: The present disclosure provides ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, method of using the engineered ketoreductase enzymes to synthesize a variety of chirally pure compounds, and the chirally pure compounds prepared therewith.
    Type: Application
    Filed: August 9, 2012
    Publication date: February 14, 2013
    Applicant: CODEXIS, INC.
    Inventors: Lorraine Joan Giver, Lisa Marie Newman, Emily Mundorff, Gjalt W. Huisman, Stephane J. Jenne, Jun Zhu, Behnaz Behrouzian, John H. Grate, James Lalonde
  • Publication number: 20120289709
    Abstract: The present disclosure provides substantially enantiomerically pure heterobicyclic compounds of the following structural formulas, wherein A, M, M?, and R5 are as described herein, and to biocatalytic processes for their preparation, and to the enzymes used in those processes.
    Type: Application
    Filed: May 7, 2012
    Publication date: November 15, 2012
    Applicant: CODEXIS, INC.
    Inventors: James Lalonde, Tao Li, Jack Liang, Benjamin Mijts, Roger Sheldon, George S.K. Wong, Aleksey Zaks
  • Publication number: 20120276599
    Abstract: The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize chiral compounds.
    Type: Application
    Filed: June 15, 2012
    Publication date: November 1, 2012
    Applicants: PFIZER, INC., CODEXIS, INC.
    Inventors: Jack Liang, Stephane J. Jenne, Emily Mundorff, Rama Voladri, James Lalonde, Gjalt W. Huisman
  • Publication number: 20120244581
    Abstract: The present disclosure provides substantially enantiomerically pure heterobicyclic compounds of the following structural formulas, wherein A, M, M?, and R5 are as described herein, and to biocatalytic processes for their preparation, and to the enzymes used in those processes.
    Type: Application
    Filed: March 30, 2012
    Publication date: September 27, 2012
    Applicant: CODEXIS, INC.
    Inventors: Benjamin Mijts, Sheela Muley, Jack Liang, Lisa M. Newman, Xiyun Zhang, James Lalonde, Michael D. Clay, Jun Zhu, John M. Gruber, Jeffrey Colbeck, John D. Munger, JR., Jagadeesh Mavinahalli, Roger Sheldon
  • Patent number: 8273547
    Abstract: The present disclosure provides ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, method of using the engineered ketoreductase enzymes to synthesize a variety of chirally pure compounds, and the chirally pure compounds prepared therewith.
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: September 25, 2012
    Assignee: Codexis, Inc.
    Inventors: Lorraine Joan Giver, Lisa Marie Newman, Emily Mundorff, Gjalt W. Huisman, Stephane J. Jenne, Jun Zhu, Behnaz Behrouzian, John H. Grate, James Lalonde
  • Patent number: 8227229
    Abstract: The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize chiral compounds.
    Type: Grant
    Filed: May 18, 2011
    Date of Patent: July 24, 2012
    Assignees: Codexis, Inc., Pfizer, Inc.
    Inventors: Jack Liang, Stephane J. Jenne, Emily Mundorff, Rama Voladri, James LaLonde, Gjalt W. Huisman
  • Publication number: 20120184000
    Abstract: The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds.
    Type: Application
    Filed: December 19, 2011
    Publication date: July 19, 2012
    Applicant: CODEXIS, INC.
    Inventors: Jack Liang, Birthe Borup, Vesna Mitchell, Emily Mundorff, James Lalonde, Gjalt Huisman